177 related articles for article (PubMed ID: 30859331)
1. Things get broken: the hypoxia-inducible factor prolyl hydroxylases in ischemic heart disease.
Schreiber T; Salhöfer L; Quinting T; Fandrey J
Basic Res Cardiol; 2019 Mar; 114(3):16. PubMed ID: 30859331
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.
Selvaraju V; Parinandi NL; Adluri RS; Goldman JW; Hussain N; Sanchez JA; Maulik N
Antioxid Redox Signal; 2014 Jun; 20(16):2631-65. PubMed ID: 23992027
[TBL] [Abstract][Full Text] [Related]
3. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
4. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
[TBL] [Abstract][Full Text] [Related]
5. Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic-Ischemic Injury in the Neonatal Rat.
Chu HX; Jones NM
Neurochem Res; 2016 Mar; 41(3):515-22. PubMed ID: 26108712
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.
Rabinowitz MH
J Med Chem; 2013 Dec; 56(23):9369-402. PubMed ID: 23977883
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus.
Wall AM; Corcoran AE; O'Halloran KD; O'Connor JJ
Neurobiol Dis; 2014 Feb; 62():8-17. PubMed ID: 24055213
[TBL] [Abstract][Full Text] [Related]
8. The PHD1 oxygen sensor in health and disease.
Kennel KB; Burmeister J; Schneider M; Taylor CT
J Physiol; 2018 Sep; 596(17):3899-3913. PubMed ID: 29435987
[TBL] [Abstract][Full Text] [Related]
9. Prolyl hydroxylases and therapeutics.
Smith TG; Talbot NP
Antioxid Redox Signal; 2010 Apr; 12(4):431-3. PubMed ID: 19761407
[TBL] [Abstract][Full Text] [Related]
10. Genetic Knockdown and Pharmacologic Inhibition of Hypoxia-Inducible Factor (HIF) Hydroxylases.
Pickel C; Taylor CT; Scholz CC
Methods Mol Biol; 2018; 1742():1-14. PubMed ID: 29330785
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-Inducible Factor α and Hif-prolyl Hydroxylase Characterization and Gene Expression in Short-Time Air-Exposed Mytilus galloprovincialis.
Giannetto A; Maisano M; Cappello T; Oliva S; Parrino V; Natalotto A; De Marco G; Barberi C; Romeo O; Mauceri A; Fasulo S
Mar Biotechnol (NY); 2015 Dec; 17(6):768-81. PubMed ID: 26277612
[TBL] [Abstract][Full Text] [Related]
12. Adaptive response to hypoxia and remote ischaemia pre-conditioning: a new hypoxia-inducible factors era in clinical medicine.
Heyman SN; Leibowitz D; Mor-Yosef Levi I; Liberman A; Eisenkraft A; Alcalai R; Khamaisi M; Rosenberger C
Acta Physiol (Oxf); 2016 Apr; 216(4):395-406. PubMed ID: 26449466
[TBL] [Abstract][Full Text] [Related]
13. Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.
Chan MC; Atasoylu O; Hodson E; Tumber A; Leung IK; Chowdhury R; Gómez-Pérez V; Demetriades M; Rydzik AM; Holt-Martyn J; Tian YM; Bishop T; Claridge TD; Kawamura A; Pugh CW; Ratcliffe PJ; Schofield CJ
PLoS One; 2015; 10(7):e0132004. PubMed ID: 26147748
[TBL] [Abstract][Full Text] [Related]
14. Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner.
Li L; Saliba P; Reischl S; Marti HH; Kunze R
Neurobiol Dis; 2016 Jul; 91():221-35. PubMed ID: 27001147
[TBL] [Abstract][Full Text] [Related]
15. Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors.
Holt-Martyn JP; Chowdhury R; Tumber A; Yeh TL; Abboud MI; Lippl K; Lohans CT; Langley GW; Figg W; McDonough MA; Pugh CW; Ratcliffe PJ; Schofield CJ
ChemMedChem; 2020 Feb; 15(3):270-273. PubMed ID: 31751494
[TBL] [Abstract][Full Text] [Related]
16. Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism.
Nguyen TL; Durán RV
Int J Biochem Cell Biol; 2016 Nov; 80():71-80. PubMed ID: 27702652
[TBL] [Abstract][Full Text] [Related]
17. The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.
Yu M; Lun J; Zhang H; Zhu L; Zhang G; Fang J
Int J Biochem Cell Biol; 2021 Jun; 135():105982. PubMed ID: 33894356
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
Koivunen P; Kietzmann T
Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
[TBL] [Abstract][Full Text] [Related]
19. Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection.
Requena-Ibáñez JA; Santos-Gallego CG; Rodriguez-Cordero A; Zafar MU; Badimon JJ
Cardiovasc Drugs Ther; 2022 Dec; 36(6):1187-1196. PubMed ID: 34533692
[TBL] [Abstract][Full Text] [Related]
20. The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.
Binó L; Kučera J; Štefková K; Švihálková Šindlerová L; Lánová M; Kudová J; Kubala L; Pacherník J
Chem Biol Interact; 2016 Jan; 244():204-14. PubMed ID: 26723917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
